Viatris Inc.
Viatris Inc. logo
VTRS

Viatris Inc. (VTRS)

$11.940.42%

Market is closed
– opens on 8 PM, 31 Jan 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$11.79
Day's Range
$12.005
$8.33
52-Week Range
$14.97
1 month return4.92%
3 month return17.87%
1 year return20.24%
5 year return26.93%

Analyst Recommendation

based on 21 analysts ratings

Hold
42%
Buy
57%
Hold
0%
Sell

Based on 21 Wall street analysts offering stock ratings for Viatris Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 27.14%

Current

$11.94

Target

$15.18

Recommendation Trend

Based on 21 analyst

Current1M Ago3M Ago
Buy
9
10
10
Hold
12
9
8
Sell
0
2
2
Consensus
HOLD
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization14.5B
Book Value$15.82
Dividend Share0.48
Dividend Yield4.1000000000000005%
Earnings Per Share (EPS)0.66
PE Ratio18.1
Wall Street Target Price15.18

Valuation

Trailing PE18.1
Forward PE3.35
Price/Book (mrq)0.68
Enterprise Value32.3B
Enterprise Value/Revenue1.93
Enterprise Value/Ebitda6.97

Technicals

Beta1.17
50 Day MA11.28
200 Day MA10.52

Institutional Holdings

Vanguard Group Inc

12.09%

BlackRock Inc

7.49%

State Street Corporation

5.08%

Davis Selected Advisers

4.57%

Camber Capital Management LLC

2.47%

T. Rowe Price Associates, Inc.

2.36%

Company Information

Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. It provides access to medicines, advance sustainable operations, develop innovative solutions and leverage its collective expertise to connect more people to more products and services through its one-of-a-kind Global Healthcare GatewayTM. Formed in November 2020through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghaiand Hyderabad, India.
OrganizationViatris Inc.
Employees37000
CEOMr. Robert J. Coury
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Viatris Inc. share price today?

Can Indians buy Viatris Inc. shares?

How can I buy Viatris Inc. shares from India?

Can Fractional shares of Viatris Inc. be purchased?

What are the documents required to start investing in Viatris Inc. stocks?

What are today’s High and Low prices of Viatris Inc.?

What are today’s traded volumes of Viatris Inc.?

What is today’s market capitalisation of Viatris Inc.?

What is the 52 Week High and Low Range of Viatris Inc.?

How much percentage Viatris Inc. is down from its 52 Week High?

How much percentage Viatris Inc. is up from its 52 Week low?

What are the historical returns of Viatris Inc.?

Who is the Chief Executive Officer (CEO) of Viatris Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*